» Articles » PMID: 26483897

The Hypocretins (orexins) Mediate the "phasic" Components of REM Sleep: A New Hypothesis

Overview
Journal Sleep Sci
Publisher Thieme
Date 2015 Oct 21
PMID 26483897
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In 1998, a group of phenotypically distinct neurons were discovered in the postero-lateral hypothalamus which contained the neuropeptides hypocretin 1 and hypocretin 2 (also called orexin A and orexin B), which are excitatory neuromodulators. Hypocretinergic neurons project throughout the central nervous system and have been involved in the generation and maintenance of wakefulness. The sleep disorder narcolepsy, characterized by hypersomnia and cataplexy, is produced by degeneration of these neurons. The hypocretinergic neurons are active during wakefulness in conjunction with the presence of motor activity that occurs during survival-related behaviors. These neurons decrease their firing rate during non-REM sleep; however there is still controversy upon the activity and role of these neurons during REM sleep. Hence, in the present report we conducted a critical review of the literature of the hypocretinergic system during REM sleep, and hypothesize a possible role of this system in the generation of REM sleep.

Citing Articles

Treatment of Narcolepsy Type 1 With Orexin: A Systematic Review.

Thomaz T, McBenedict B, Meireles D, Farias G, Almeida L, de Almeida Leitao M Cureus. 2025; 16(12):e76692.

PMID: 39898129 PMC: 11781994. DOI: 10.7759/cureus.76692.


Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control.

Bandarabadi M, Li S, Aeschlimann L, Colombo G, Tzanoulinou S, Tafti M Mol Psychiatry. 2023; 29(2):327-341.

PMID: 38123729 PMC: 11116111. DOI: 10.1038/s41380-023-02329-z.


Sleep, Narcolepsy, and Sodium Oxybate.

Mamelak M Curr Neuropharmacol. 2021; 20(2):272-291.

PMID: 33827411 PMC: 9413790. DOI: 10.2174/1570159X19666210407151227.


Orexin signaling modulates synchronized excitation in the sublaterodorsal tegmental nucleus to stabilize REM sleep.

Feng H, Wen S, Qiao Q, Pang Y, Wang S, Li H Nat Commun. 2020; 11(1):3661.

PMID: 32694504 PMC: 7374574. DOI: 10.1038/s41467-020-17401-3.


Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.

Kubin L Compr Physiol. 2016; 6(4):1801-1850.

PMID: 27783860 PMC: 5242202. DOI: 10.1002/cphy.c160002.


References
1.
Fung S, Yamuy J, Sampogna S, Morales F, Chase M . Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study. Brain Res. 2001; 903(1-2):257-62. DOI: 10.1016/s0006-8993(01)02318-6. View

2.
Xi M, Chase M . The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered. Sleep. 2010; 33(9):1236-43. PMC: 2938865. DOI: 10.1093/sleep/33.9.1236. View

3.
McGregor R, Damian A, Fabbiani G, Torterolo P, Pose I, Chase M . Direct hypothalamic innervation of the trigeminal motor nucleus: a retrograde tracer study. Neuroscience. 2005; 136(4):1073-81. DOI: 10.1016/j.neuroscience.2005.08.028. View

4.
de Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P . The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998; 95(1):322-7. PMC: 18213. DOI: 10.1073/pnas.95.1.322. View

5.
Shekhar A, Dimicco J . Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. Neuropharmacology. 1987; 26(5):407-17. DOI: 10.1016/0028-3908(87)90020-7. View